These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9755905)

  • 1. The roles of depot injection sites and proximal lymph nodes in the presystemic absorption of fluphenazine decanoate and fluphenazine: ex vivo experiments in rats.
    Luo JP; Hubbard JW; Midha KK
    Pharm Res; 1998 Sep; 15(9):1485-9. PubMed ID: 9755905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the mechanism of absorption of depot neuroleptics: fluphenazine decanoate in sesame oil.
    Luo JP; Hubbard JW; Midha KK
    Pharm Res; 1997 Aug; 14(8):1079-84. PubMed ID: 9279892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacokinetics of the depot antipsychotics.
    Jann MW; Ereshefsky L; Saklad SR
    Clin Pharmacokinet; 1985; 10(4):315-33. PubMed ID: 2864156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absorption of intramuscularly administered [14C]haloperidol decanoate in rats.
    Matsunaga Y; Nambu K; Oh-e Y; Miyazaki H; Hashimoto M
    Eur J Drug Metab Pharmacokinet; 1987; 12(3):175-81. PubMed ID: 3436339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluphenazine enanthate and fluphenazine decanoate: intramuscular injection and esterification as requirements for slow - release characteristics in dogs.
    Dreyfuss J; Shaw JM; Ross JJ
    J Pharm Sci; 1976 Sep; 65(9):1310-5. PubMed ID: 966144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release and elimination of 14C-fluphenazine enanthate and decanoate esters administered in sesame oil to dogs.
    Dreyfuss J; Ross JJ; Shaw JM; Miller I; Schreiber EC
    J Pharm Sci; 1976 Apr; 65(4):502-507. PubMed ID: 1271246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring plasma levels of fluphenazine during chronic therapy with fluphenazine decanoate.
    Miller RS; Peterson GM; McLean S; Westhead TT; Gillies P
    J Clin Pharm Ther; 1995 Apr; 20(2):55-62. PubMed ID: 7650075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood and plasma kinetics of cis(Z)-clopenthixol and fluphenazine in psychiatric patients after intramuscular injection of their decanoic esters.
    Viala A; Hou N; Ba B; Durand A; Dufour H; D'Agostino N; Berda C; Jørgensen A
    Psychopharmacology (Berl); 1984; 83(2):147-50. PubMed ID: 6146995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of fluphenazine decanoate. Effects of site of injection, massage and muscle activity.
    Soni SD; Wiles D; Schiff AA; Bamrah JS
    Br J Psychiatry; 1988 Sep; 153():382-4. PubMed ID: 3250675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted delivery of a model immunomodulator to the lymphatic system: comparison of alkyl ester versus triglyceride mimetic lipid prodrug strategies.
    Han S; Quach T; Hu L; Wahab A; Charman WN; Stella VJ; Trevaskis NL; Simpson JS; Porter CJ
    J Control Release; 2014 Mar; 177():1-10. PubMed ID: 24398334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioconversion and P-gp-Mediated Transport of Depot Fluphenazine Prodrugs after Intramuscular Injection.
    Ohura K; Nakada Y; Imai T
    J Pharm Sci; 2023 Jul; 112(7):1975-1984. PubMed ID: 37019360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-dose pharmacokinetics of fluphenazine after fluphenazine decanoate administration.
    Simpson GM; Yadalam KG; Levinson DF; Stephanos MJ; Lo ES; Cooper TB
    J Clin Psychopharmacol; 1990 Dec; 10(6):417-21. PubMed ID: 2286711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of haloperidol and fluphenazine decanoates in chronic schizophrenia.
    Wiles DH; McCreadie RG; Whitehead A
    Psychopharmacology (Berl); 1990; 101(2):274-81. PubMed ID: 2349370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of the pharmacokinetics of zuclopenthixol decanoate and fluphenazine decanoate.
    Viala A; Ba B; Durand A; Gouezo F; Hou N; Jørgensen A
    Psychopharmacology (Berl); 1988; 94(3):293-7. PubMed ID: 2895936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind comparison of haloperidol decanoate and fluphenazine decanoate effectiveness, side-effects, dosage and serum levels during a six months' treatment for relapse prevention.
    Kissling W; Möller HJ; Walter K; Wittmann B; Krueger R; Trenk D
    Pharmacopsychiatry; 1985 May; 18(3):240-5. PubMed ID: 4011672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of fluphenazine after fluphenazine dihydrochloride, enanthate and decanoate administration to man.
    Curry SH; Whelpton R; de Schepper PJ; Vranckx S; Schiff AA
    Br J Clin Pharmacol; 1979 Apr; 7(4):325-31. PubMed ID: 444352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitive method for the simultaneous measurement of fluphenazine decanoate and fluphenazine in plasma by high-performance liquid chromatography with coulometric detection.
    Luo JP; Hubbard JW; Midha KK
    J Chromatogr B Biomed Sci Appl; 1997 Jan; 688(2):303-8. PubMed ID: 9061468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depot fluphenazine decanoate and enanthate for schizophrenia.
    David A; Adams CE; Eisenbruch M; Quraishi S; Rathbone J
    Cochrane Database Syst Rev; 2005 Jan; (1):CD000307. PubMed ID: 15674872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and toxicological profile of fluphenazine decanoate in elderly chronic schizophrenia.
    Altamura AC; Mauri MC; Girardi T; Panetta B
    Int J Clin Pharmacol Res; 1990; 10(4):223-8. PubMed ID: 2079381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of haloperidol decanoate in rats.
    Oh-e Y; Miyazaki H; Matsunaga Y; Hashimoto M
    J Pharmacobiodyn; 1991 Nov; 14(11):615-22. PubMed ID: 1687285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.